Cargando…
Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids
Combination therapy is being increasingly used as a treatment paradigm for metabolic diseases such as diabetes and obesity. In the peptide therapeutics realm, recent work has highlighted the therapeutic potential of chimeric peptides that act on two distinct receptors, thereby harnessing parallel co...
Autores principales: | Trevaskis, James L., Mack, Christine M., Sun, Chengzao, Soares, Christopher J., D’Souza, Lawrence J., Levy, Odile E., Lewis, Diane Y., Jodka, Carolyn M., Tatarkiewicz, Krystyna, Gedulin, Bronislava, Gupta, Swati, Wittmer, Carrie, Hanley, Michael, Forood, Bruce, Parkes, David G., Ghosh, Soumitra S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805588/ https://www.ncbi.nlm.nih.gov/pubmed/24167604 http://dx.doi.org/10.1371/journal.pone.0078154 |
Ejemplares similares
-
Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
por: Levy, Odile E., et al.
Publicado: (2014) -
A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents
por: Tatarkiewicz, K, et al.
Publicado: (2014) -
Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice
por: Tatarkiewicz, K, et al.
Publicado: (2014) -
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial
por: Tiessen, Renger G., et al.
Publicado: (2018) -
Amylin/leptin synergy is absent in extreme obesity and not restored by calorie restriction‐induced weight loss in rats
por: Trevaskis, J. L., et al.
Publicado: (2016)